LexDanaLexDanabeta
Inventor

Kelly Sullivan Kraft

Inventor
Poughquag, NY, US

Overview

22→
Patents
2006–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes34%
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C07CAcyclic or carbocyclic compounds15%
A61MDevices for introducing media into, or onto, the body6%
PatentTitleYear
10,870,628Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic a-N-protected amino ester202010,858,325Methods for the synthesis of activated ethylfumarates and their use as intermediates202010,577,331Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester intermediate202010,172,850Substituted diketopiperazine analogs for use as drug delivery agents201910,071,969Methods for the synthesis of activated ethylfumarates and their use as intermediates20189,944,609Formation of N-protected bis-3,6-(4-aminobutyl)-2, 5-diketopiperazine through a cyclic alpha-N-protected amino ester20189,655,850'Substituted diketopiperazine analogs for use as drug delivery agents'20179,446,133'Dry powder inhaler and system for drug delivery'20169,220,687'Substituted diketopiperazine analogs for use as drug delivery agents'20159,192,675'Dry powder inhaler and system for drug delivery'20159,193,691'Methods for the synthesis of activated ethylfumarates and their use as intermediates'20159,187,433'Formation of N-protected 3,6-bis-(4-aminobutyl) -2, 5-diketopiperazine through a cyclic α-N-protected active amino ester intermediate'20158,962,836'Formation of N-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester'20158,912,193'Dry powder inhaler and system for drug delivery'20148,906,926'Substituted diketopiperazine analogs for use as drug delivery agents'20148,410,309'Phenoxy carboxylic acid compounds and compositions for delivering active agents'20138,314,106'Substituted diketopiperazine analogs for use as drug delivery agents'20128,227,409'Diketopiperazine microparticles with defined isomer contents'20127,951,971'Phenoxy carboxylic acid compounds and compositions for delivering active agents'20117,297,794'Phenoxy amine compounds and compositions for delivering active agents'20077,279,597'Phenyl amine carboxylic acid compounds and compositions for delivering active agents'20077,129,274'Phenoxy carboxylic acid compounds and compositions for delivering active agents'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2013Patents assigned to EMISPHERE TECH INC (5)· patent assignee history
2006–2015Based in Hopewell Junction, NY, US· patent location history
2012–2020Patents assigned to MANNKIND CORP (17)· patent assignee history
2012–2014Patents assigned to KRAFT KELLY SULLIVAN (2)· patent assignee history
2012–2020Based in Poughquag, NY, US· patent location history
2013Patents assigned to BOYD MARIA AURORA P (1)· patent assignee history
2013Patents assigned to FREEMAN JR JOHN J (1)· patent assignee history
2014Based in Poughqaug, NY, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MANNKIND CORP172012–2020
EMISPHERE TECH INC52006–2013
KRAFT KELLY SULLIVANself22012–2014
BOYD MARIA AURORA P12013
FREEMAN JR JOHN J12013
Locations
LocationPatentsSpan
Poughquag, New York, US132012–2020
Hopewell Junction, New York, US82006–2015
Poughqaug, New York, US12014